July/August #146 : Bad Combos ...and the Women Who Take Them - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Torch Song

Service Interruption

AIDS on the Border

Staying Put?

Bad Combos ...and the Women Who Take Them

Move It, Doc!

Stem Cell Surprise

At the Drugstore: Do You Get What You Pay For?

Adherence Tip: It's In the Bag

When to Treat

Tai Chi for T Cells

So Long, Salmonella

Field of Genes

PI Solo Act

Sound Like a Plan?

That's Hot!

Death on the Nile

Operation Iraqi Stigma

Starter Wives

Pos or Not?

Surf's Up!

Postcard From the Edge

HIV Info, Str8 2 UR Fone

Hot Dates-July/August 2008

In or Out?

Mile-High Hopes

Editor's Letter-July/August 2008

Mailbox-July/August 2008

GMHC Treatment Issues-July/August 2008

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

Scroll down to comment on this story.

email print

July / August 2008

Bad Combos ...and the Women Who Take Them

by Laura Whitehorn

Between 1998 and 2004, some 17 percent of HIV-positive women observed in a U.S. survey—the Women’s Interagency HIV Study (WIHS)—were taking HIV med regimens deemed ineffective or dangerous by federal treatment guidelines. Some of the combos included meds from only one or two HIV-drug classes; others combined meds known to interact badly. An author of the Journal of AIDS study report, Jennifer Cocohoba, PharmD, of the University of California San Francisco, calls the regimens “contraindicated” (they shouldn’t be used) and the findings “shocking,” though she warned that the 217-woman survey hinged on interviews, not prescription records.

Because the federal guidelines for HIV treatment are periodically adjusted to reflect new research, each woman’s first combo was rated based on guidelines for the year she began meds. Doctors weren’t interviewed about why they’d prescribed the combos, but one possible explanation emerged: The 37 women on contraindicated regimens had lower starting viral loads than the other women, suggesting that their doctors might have thought only partial regimens were required. That proved wrong: The women in the bad-combo group had slower, lower CD4 gains and higher viral loads than the others—even after switching to a better combo. (An additional 64 women were on regimens that were not recommended, but not deemed dangerous, by the guidelines.)

Fewer women took contraindicated drugs after 2001, says Cocohoba, “but it’s a reminder that women seek HIV specialists less often than men.” Whatever the reason for those bad regimens, the study results serve notice on all positive people—and their doctors—to triple-check that combo.      

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.